<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>49</volume><submitter>Zimmerman DE</submitter><pubmed_abstract>The year 2020 was not easy for Emergency Medicine (EM) clinicians with the burden of tackling a pandemic. A large focus, rightfully so, was placed on the evolving diagnosis and management of patients with COVID-19 and, as such, the ability of clinicians to remain up to date on key EM pharmacotherapy literature may have been compromised. This article reviews the most important EM pharmacotherapy publications indexed in 2020. A modified Delphi approach was utilized for selected journals to identify the most impactful EM pharmacotherapy studies. A total of fifteen articles, eleven trials and four meta-analyses, were identified. This review provides a summary of each study, along with a commentary on the impact to the EM literature and EM clinician.</pubmed_abstract><journal>The American journal of emergency medicine</journal><pagination>200-205</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8204853</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Staying InformED: Top emergency Medicine pharmacotherapy articles of 2020.</pubmed_title><pmcid>PMC8204853</pmcid><pubmed_authors>Gilbert BW</pubmed_authors><pubmed_authors>Porter BA</pubmed_authors><pubmed_authors>Laub J</pubmed_authors><pubmed_authors>Faine B</pubmed_authors><pubmed_authors>Flack T</pubmed_authors><pubmed_authors>Zimmerman DE</pubmed_authors><pubmed_authors>Sarangarm P</pubmed_authors><pubmed_authors>Howington GT</pubmed_authors><pubmed_authors>Brown CS</pubmed_authors><pubmed_authors>Kelly G</pubmed_authors><pubmed_authors>Rech MA</pubmed_authors><pubmed_authors>Slocum GW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Staying InformED: Top emergency Medicine pharmacotherapy articles of 2020.</name><description>The year 2020 was not easy for Emergency Medicine (EM) clinicians with the burden of tackling a pandemic. A large focus, rightfully so, was placed on the evolving diagnosis and management of patients with COVID-19 and, as such, the ability of clinicians to remain up to date on key EM pharmacotherapy literature may have been compromised. This article reviews the most important EM pharmacotherapy publications indexed in 2020. A modified Delphi approach was utilized for selected journals to identify the most impactful EM pharmacotherapy studies. A total of fifteen articles, eleven trials and four meta-analyses, were identified. This review provides a summary of each study, along with a commentary on the impact to the EM literature and EM clinician.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2025-05-29T19:24:20.664Z</modification><creation>2022-02-11T12:17:35.424Z</creation></dates><accession>S-EPMC8204853</accession><cross_references><pubmed>34139435</pubmed><doi>10.1016/j.ajem.2021.05.061</doi></cross_references></HashMap>